The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study

To report additional ocular outcomes of intensive treatment of hyperglycemia, blood pressure, and dyslipidemia in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study. Double 2×2 factorial, multicenter, randomized clinical trials in people with type 2 diabetes who had cardiovascular...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 2014-12, Vol.121 (12), p.2443
Hauptverfasser:	Chew, Emily Y, Davis, Matthew D, Danis, Ronald P, Lovato, James F, Perdue, Letitia H, Greven, Craig, Genuth, Saul, Goff, David C, Leiter, Lawrence A, Ismail-Beigi, Faramarz, Ambrosius, Walter T
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Cardiovascular Diseases - prevention & control Cataract Extraction - statistics & numerical data Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetic Retinopathy - etiology Diabetic Retinopathy - prevention & control Disease Progression Female Fenofibrate - therapeutic use Humans Hyperglycemia - drug therapy Hyperglycemia - etiology Hypolipidemic Agents - therapeutic use Macular Edema - diagnosis Male Middle Aged Outcome Assessment, Health Care Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To report additional ocular outcomes of intensive treatment of hyperglycemia, blood pressure, and dyslipidemia in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study. Double 2×2 factorial, multicenter, randomized clinical trials in people with type 2 diabetes who had cardiovascular disease or cardiovascular risk factors. In the glycemia trial, targets of intensive and standard treatment were: hemoglobin A1c
ISSN:	1549-4713 1549-4713
DOI:	10.1016/j.ophtha.2014.07.019